GGrantIndex
Sort

326,823 grants matching clinical trial

Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose

$10,316,802
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

Cannabidiol in the treatment of opioid use disorder

$10,316,590
Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · UH3 · FY2024 · DA

Regulatory Support Services

$10,312,316
Laura McNay · National Institute Of Allergy And Infectious Diseases · ZID · FY2009 · AI

Clinical Agent and Specimen Repository

$10,311,856
Katherine Babay · Fisher Bioservices, Inc. · N01 · FY2011 · AI

NRG Oncology - Statistical and Data Management Center

$10,307,634
James J. Dignam · University Of Chicago · U10 · FY2020 · CA

Clinical and Translational Science Award

$10,299,800
Muredach P Reilly · Columbia University Health Sciences · UL1 · FY2023 · TR

HEAL: Development of Clinical Candidate Drugs for Pain, Addiction and Overdose

$10,299,226
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

Inter- and Intra-Species Comparative Sequencing

$10,295,725
James C Mullikin · National Human Genome Research Institute · ZIB · FY2022 · HG

Clinical and Translational Science Award

$10,288,366
Muredach P Reilly · Columbia University Health Sciences · UL1 · FY2024 · TR

NICHD Office of the Clinical Director

$10,268,240
Laverne Mensah · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZID · FY2023 · HD

Institutional Clinical and Translational Science Award

$10,260,197
Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2022 · TR

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)

$10,257,187
Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2023 · AG

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies

$10,254,288
Anthony O Caggiano · Cognition Therapeutics, Inc. · R01 · FY2022 · AG

New England Regional Center of Excellence for Biodefense

$10,253,895
Dennis L. Kasper · Harvard Medical School · U54 · FY2007 · AI

HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUP

$10,253,865
Fred Hutchinson Cancer Research Center · U01 · FY2004 · AI

Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy Center

$10,242,127
Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA

SDMC: HIV Vaccine Trials Network

$10,240,739
Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2014 · AI

Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET)

$10,225,990
Abhik Das · Research Triangle Institute · U24 · FY2023 · HD

NRG Oncology - Statistical and Data Management Center

$10,210,029
James J. Dignam · University Of Chicago · U10 · FY2025 · CA

VA-Perry Point Cooperative Studies Program

$10,207,014
National Institute On Drug Abuse · Y01 · FY2013 · DA

Southwest Oncology Group Treatment Grant

$10,205,783
Laurence H Baker · University Of Michigan At Ann Arbor · U10 · FY2010 · CA

NIAAA Medications Development Data Coordinating Center

$10,204,539
Janet Ransom · Fast Track Drugs & Biologics, Llc · N01 · FY2011 · AA

Imaging and Radiation Oncology Core (IROC) Group

$10,203,250
Stephen F Kry · American College Of Radiology · U24 · FY2023 · CA

Data Coordinating Center for the NICHD Neonatal Research Network (U24)

$10,200,000
Abhik Das · Research Triangle Institute · U24 · FY2021 · HD

Clinical Pharmacodynamics

$10,200,000
Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA